| Title: |
Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data |
| Authors: |
Brueggemann, Angela, B; Jansen van Rensburg, Melissa, J; Shaw, David; Mccarthy, Noel, D; Jolley, Keith, A; Maiden, Martin, C J; van Der Linden, Mark, P G; Amin-Chowdhury, Zahin; Bennett, Désirée, E; Borrow, Ray; Brandileone, Maria-Cristina, C; Broughton, Karen; Campbell, Ruth; Cao, Bin; Casanova, Carlo; Choi, Eun Hwa; Chu, Yiu Wai; Clark, Stephen, A; Claus, Heike; Coelho, Juliana; Corcoran, Mary; Cottrell, Simon; Cunney, Robert, J; Dalby, Tine; Davies, Heather; de Gouveia, Linda; Deghmane, Ala-Eddine; Demczuk, Walter; Desmet, Stefanie; Drew, Richard; Du Plessis, Mignon; Erlendsdottir, Helga; Fry, Norman, K; Fuursted, Kurt; Gray, Steve, J; Henriques-Normark, Birgitta; Hale, Thomas; Hilty, Markus; Hoffmann, Steen; Humphreys, Hilary; Ip, Margaret; Jacobsson, Susanne; Johnston, Jillian; Kozakova, Jana; Kristinsson, Karl, G; Krizova, Pavla; Kuch, Alicja; Ladhani, Shamez, N; Lâm, Thiên-Trí; Lebedova, Vera; Lindholm, Laura; Litt, David, J; Martin, Irene; Martiny, Delphine; Mattheus, Wesley; Mcelligott, Martha; Meehan, Mary; Meiring, Susan; Mölling, Paula; Morfeldt, Eva; Morgan, Julie; Mulhall, Robert, M; Muñoz-Almagro, Carmen; Murdoch, David, R; Murphy, Joy; Musilek, Martin; Mzabi, Alexandre; Perez-Argüello, Amaresh; Perrin, Monique; Perry, Malorie; Redin, Alba; Roberts, Richard; Roberts, Maria; Rokney, Assaf; Ron, Merav; Scott, Kevin, J; Sheppard, Carmen, L; Siira, Lotta; Skoczyńska, Anna; Sloan, Monica; Slotved, Hans-Christian; Smith, Andrew, J; Song, Joon Young; Taha, Muhamed-Kheir; Toropainen, Maija; Tsang, Dominic; Vainio, Anni; van Sorge, Nina, M; Varon, Emmanuelle; Vlach, Jiri; Vogel, Ulrich; Vohrnova, Sandra; von Gottberg, Anne; Zanella, Rosemeire, C; Zhou, Fei |
| Contributors: |
University of Oxford; Trinity College Dublin; Department of Zoology Oxford; Universitätsklinikum RWTH Aachen - University Hospital Aachen Aachen, Germany (UKA); RWTH Aachen University = Rheinisch-Westfälische Technische Hochschule Aachen (RWTH Aachen); Public Health England London; Beaumont Hospital Dublin, Ireland; Manchester Royal Infirmary; University of Manchester Manchester; Instituto Adolfo Lutz São Paulo, Brazil; Public Health Agency Belfast; China Academy of Chinese Medical Sciences; Universität Bern = University of Bern = Université de Berne (UNIBE); Seoul National University College of Medicine Séoul, Corée du Sud (SNUCM); The Government of the Hong Kong Special Administrative Region (GovHK); Julius-Maximilians-Universität Würzburg = University of Würzburg Würsburg, Germany (JMU); Children's Health Ireland; Public Health Wales; National Institute of Public Health Prague; Institute of Environmental Science and Research Limited; NCBID; National Institute for Communicable Diseases Johannesburg (NICD); Centre Collaborateur de l'OMS pour les méningites bactériennes - WHO Collaborating Center Bacterial Meningitis (CC-OMS - WHO-CC); Institut Pasteur Paris (IP)-Organisation Mondiale de la Santé / World Health Organization Office Genève, Suisse (OMS / WHO); Public Health Agency of Canada; Universitair Ziekenhuis Leuven = University Hospital of Leuven = Hopital universitaire de Louvain (UZ Leuven); Catholic University of Leuven = Katholieke Universiteit Leuven (KU Leuven); Landspitali National University Hospital of Iceland; Statens Serum Institut Copenhagen; Karolinska Institutet = Karolinska Institute Stockholm; Karolinska University Hospital Stockholm; The Chinese University of Hong Kong (CUHK); Örebro University; National Medicines Institute - Narodowy Instytut Leków Warsaw (NIL); Finnish Institute for Health and Welfare (FIHW); Université de Mons = University of Mons (UMONS); Laboratoires des Hôpitaux Universitaires de Bruxelles, Universitaire Laboratorium Brussel; National Reference Centre for Neisseria meningitidis Bruxelles; Public Health Agency of Sweden; Hospital Sant Joan de Déu Barcelona; Universiteit van Amsterdam = University of Amsterdam (UvA); Laboratoire National de Santé Luxembourg (LNS); Ministry of Health Jérusalem; Scottish Microbiology Reference Laboratories; College of Medicine, Korea University; Department of Biochemistry; CHI Créteil; We thank all the hospitals and clinical microbiology laboratories who submitted data and isolates to the reference laboratories as part of their surveillance programmes. We acknowledge the assistance of laboratory personnel who made important contributions to the microbiological data in this study: Wendy Keijzers, Ilse Schuurman, and Agaath Arends in the Netherlands Reference Laboratory for Bacterial Meningitis, Amsterdam, The Netherlands; Marie-Cécile Ploy, Carole Grelaud, and all the microbiologists of the French Regional Observatory of Pneumococci Network (Limoges, France); Alice Enefer, Anna Lewis, Karina Micah, Samuel Rose, Chenchal Dhami, and Roger Daniel at the Public Health England Respiratory and Vaccine Preventable Bacteria Unit, London, UK; Xilian Bai, Aiswarya Lekshmi, Jay Lucidarme, Andrew Walker, Lloyd Walsh, and Laura Willerton at the Public Health England Meningococcal Reference Unit in Manchester, UK; Ana Paula Silva de Lemos and Samanta Cristine Grassi Almeida at the National Laboratory for Meningitis and Pneumococcal Infections, São Paulo, Brazil; and the technicians from the Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark. The infrastructure for the IRIS Initiative was funded by a Wellcome Trust Investigator Award to ABB (grant number 206394/Z/17/Z) and a Wellcome Trust Biomedical Resource Grant to MJCM, ABB, and KAJ (grant number 218205/Z/19/Z). The German National Reference Center for Streptococci receives financial support from the Robert Koch Institute with funds from the Federal Ministry of Health (funding code 1369-235), Pfizer, and Merck. The German National Reference Laboratory for Meningococci and Haemophilus influenzae is supported by the Robert Koch Institute with funds from the Federal Ministry of Health (funding code 1369-237). The Irish Meningitis and Sepsis Reference Laboratory has received support from Children's Health Ireland at Temple Street, Royal College of Surgeons, Health Protection Surveillance Centre, and the SpID-Net project, which has received funding from the European Centre for Disease Prevention and Control and Horizon 2020. Children's Health Ireland at Temple Street has previously received research funds from Pfizer to partially support this work. The Polish data collection was partially supported by the Ministry of Health within the framework of the National Programme of Antibiotic Protection, by the Ministry of Science and Higher Education (Mikrobank 2 Programme), and by a research grant from Pfizer. Funding for materials, equipment, and human resources associated with the laboratory in Catalonia (Spain) was provided by Agencia de Salut Pública de Catalunya and Sant Joan de Deu Foundation. BH-N received funding from the Knut and Alice Wallenberg Foundation, the Swedish Research Council, and Region Stockholm. The Swiss National Reference Centre for Invasive Pneumococci is funded by the Federal Office of Public Health of Switzerland. The National Reference Centre for Pneumococci in Créteil (France) received funding from the French Public Health Agency.; European Project: 634446,H2020-PHC-2014-2015,H2020-PHC-2014-two-stage,I-MOVE-plus(2015) |
| Source: |
ISSN: 2589-7500 ; The Lancet Digital Health ; https://pasteur.hal.science/pasteur-03261492 ; The Lancet Digital Health, 2021, 3 (6), pp.e360-e370. ⟨10.1016/S2589-7500(21)00077-7⟩. |
| Publisher Information: |
CCSD; Elsevier |
| Publication Year: |
2021 |
| Collection: |
Institut Pasteur: HAL |
| Subject Terms: |
Respiratory and Vaccine Preventable Bacteria Reference Unit; S N Ladhani MD); Z Amin-Chowdhury BSc; Immunisation and Countermeasures Division (N K Fry PhD; MESH: Bacterial Infections; MESH: COVID-19; MESH: Public Health Practice; MESH: Respiratory Tract Infections; MESH: Streptococcus agalactiae; MESH: Streptococcus pneumoniae; MESH: Haemophilus influenzae; MESH: Humans; MESH: Incidence; MESH: Interrupted Time Series Analysis; MESH: Neisseria meningitidis; MESH: Population Surveillance; MESH: Prospective Studies; [SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology |
| Description: |
International audience ; Background: Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis, which are typically transmitted via respiratory droplets, are leading causes of invasive diseases, including bacteraemic pneumonia and meningitis, and of secondary infections subsequent to post-viral respiratory disease. The aim of this study was to investigate the incidence of invasive disease due to these pathogens during the early months of the COVID-19 pandemic.Methods: In this prospective analysis of surveillance data, laboratories in 26 countries and territories across six continents submitted data on cases of invasive disease due to S pneumoniae, H influenzae, and N meningitidis from Jan 1, 2018, to May, 31, 2020, as part of the Invasive Respiratory Infection Surveillance (IRIS) Initiative. Numbers of weekly cases in 2020 were compared with corresponding data for 2018 and 2019. Data for invasive disease due to Streptococcus agalactiae, a non-respiratory pathogen, were collected from nine laboratories for comparison. The stringency of COVID-19 containment measures was quantified using the Oxford COVID-19 Government Response Tracker. Changes in population movements were assessed using Google COVID-19 Community Mobility Reports. Interrupted time-series modelling quantified changes in the incidence of invasive disease due to S pneumoniae, H influenzae, and N meningitidis in 2020 relative to when containment measures were imposed.Findings: 27 laboratories from 26 countries and territories submitted data to the IRIS Initiative for S pneumoniae (62 837 total cases), 24 laboratories from 24 countries submitted data for H influenzae (7796 total cases), and 21 laboratories from 21 countries submitted data for N meningitidis (5877 total cases). All countries and territories had experienced a significant and sustained reduction in invasive diseases due to S pneumoniae, H influenzae, and N meningitidis in early 2020 (Jan 1 to May 31, 2020), coinciding with the introduction of COVID-19 containment measures ... |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| Relation: |
info:eu-repo/semantics/altIdentifier/pmid/34045002; info:eu-repo/grantAgreement//634446/EU/I-MOVE+ Integrated Monitoring of Vaccines Effects in Europe: a platform to measure and compare effectiveness and impact of influenza and pneumococcal vaccines and vaccination strategies in the elderly/I-MOVE-plus; PUBMED: 34045002; PUBMEDCENTRAL: PMC8166576 |
| DOI: |
10.1016/S2589-7500(21)00077-7 |
| Availability: |
https://pasteur.hal.science/pasteur-03261492; https://pasteur.hal.science/pasteur-03261492v1/document; https://pasteur.hal.science/pasteur-03261492v1/file/Brueggemann%20et%20al2021.pdf; https://doi.org/10.1016/S2589-7500(21)00077-7 |
| Rights: |
https://creativecommons.org/licenses/by/4.0/ ; info:eu-repo/semantics/OpenAccess |
| Accession Number: |
edsbas.5805C9EB |
| Database: |
BASE |